by Innovit Corporate Affairs | Jul 7, 2025 | Blog, Eudamed
With Innovit’s expertise, our client achieved all goals and completed M2M tests with AusUDID and EUDAMED Innovit is proud to announce that one of our clients, a global medical device company and leader in orthopedic devices, was the first to complete M2M testing...
by Innovit Corporate Affairs | Jul 7, 2025 | Blog, GDSN, Michelle Laurion
With Innovit’s expertise, our client achieved all goals and completed M2M tests with AusUDID and EUDAMED Innovit is proud to announce that one of our clients, a global medical device company and leader in orthopedic devices, was the first to complete M2M testing...
by Innovit Corporate Affairs | Jun 18, 2025 | Blog, Eudamed
With increasing global UDI regulatory demands like EUDAMED in the EU, GUDID in the US, and now AusUDID in Australia, medical device manufacturers are under pressure to ensure timely and accurate registration of their products. While some companies manage to stay well...
by Innovit Corporate Affairs | May 12, 2025 | News
We’re pleased to share that Australia’s Unique Device Identification (UDI) regulatory framework is now officially in effect, marking a major milestone in strengthening patient safety and medical device traceability. The Therapeutic Goods Legislation Amendment...
by Innovit Corporate Affairs | Feb 12, 2025 | Blog, Eudamed
EUDAMED Go-Live Announcement – Streamlined UDI Data Submission to EUDAMED using Innovit EUDAMED Connector We’re excited to announce that Innovit’s EUDAMED Connector has been successfully implemented at B. Braun, a leading medical technology company, for UDI data...
